Abstract
Limited reduction of a mixture of purified human fibrinogen and human serum albumin leads to the formation of a stable complex. This complex is clottable with thrombin, but its electrophoretic mobility is lower than that of fibrinogen. By contrast to clots prepared from purified fibrinogen, those obtained from the complex are transparent and are completely resistant to fibrinolytic degradation induced with urokinase. In this respect the complex of fibrinogen with albumin is similar to that identified in congenitally abnormal fibrinogens.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Koopman, J., Haverkate, F., Grimbergen, J., Engesser, L., Novakova, I., Kerst, A. F. J. A., and Lord, S. T. (1992).Proc. Natl. Acad. Sci. USA 89, 3478–3482.
Kshirsagar, B., Wilson, B., and Wiggins, R. C. (1984).Clin. Chim. Acta 143, 265–273.
Lipinski, B., and Egyud, L. G. (1992).Bioorg. Med. Chem. Lett. 2, 919–1992.
Lipinski, B., Federman, S. M., and Krolewski, A. S. (1994).Thromb. Haemostas. 72, 985–986.
Lipinski, B., Federman, S. M., and Krolewski, A. S. (1995).Thromb. Res., in press.
Mohammad, S. F., Sharma, N., and Woodward, S. C. (1983).Biochim. Biophys. Acta 749, 47–51.
Ropars, C., Doniel, C. H., and Salenn, J. P. (1973).Biomedicine 19, 228–230.
Van Oss, C. J. (1990).J. Protein Chem. 9, 487–491.
Wada, Y., and Lord, S. T. (1994).Blood 84, 3709–3714.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lipinski, B. In vitro preparation and partial characterization of a novel complex of human fibrinogen with albumin. J Protein Chem 14, 259–262 (1995). https://doi.org/10.1007/BF01886767
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01886767